摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-bis(1-methylethoxy)benzaldehyde | 110654-92-7

中文名称
——
中文别名
——
英文名称
2,6-bis(1-methylethoxy)benzaldehyde
英文别名
2,6-Di(propan-2-yloxy)benzaldehyde
2,6-bis(1-methylethoxy)benzaldehyde化学式
CAS
110654-92-7
化学式
C13H18O3
mdl
——
分子量
222.284
InChiKey
AHHAOOAZWDRBKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    16
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2,6-bis(1-methylethoxy)benzaldehyde吡啶盐酸羟胺 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以87%的产率得到2,6-bis(1-methylethoxy)benzaldehyde oxime
    参考文献:
    名称:
    Synthesis of 2,6-disubstituted benzylamine derivatives as reversible selective inhibitors of copper amine oxidases
    摘要:
    In order to obtain substrate-like inhibitors of copper amine oxidases (CAOs), a class of enzymes involved in important cellular processes as well as in crosslinking of elastin and collagen and removal of biogenic primary amines, we synthesized a set of benzylamine derivatives properly substituted at positions 2 and 6 and studied their biological activity towards some members of CAOs.With benzylamines 6, 7, 8 containing linear alkoxy groups we obtained reversible inhibitors of benzylamine oxidase (BAO), very active and selective toward diamine oxidase (DAO), lysyl oxidase (LO) and monoamine oxidase B (MAO B) characterized by a certain toxicity consequent to the crossing of the brain barrier. Poorly toxic, up to very active, reversible inhibitors of BAO, very selective toward DAO, LO and MAO B, were obtained with benzylamines 10, 11, 12 containing hydrophilic x-hydroxyalkoxy groups. With benzylamines 13, 14, 15, containing linear alkyl groups endowed with steric, but not conjugative effects for the absence of properly positioned oxygen atoms, we synthesized moderately active inhibitors of BAO reversible and selective toward DAO, LO and MAO B.The cross examination of the entire biological data brought us to the conclusion that the bioactive synthesized compounds most likely exert their physiological role of reversible inhibitors in consequence of the formation of a plurality of hydrogen bonds or hydrophobic non-covalent interactions with proper sites in the protein. Accordingly, the reported inhibitors may be considered as a set of research tools for general biological studies and the formation of enzyme complexes useful for X-ray structure determinations aimed at the design of more sophisticated inhibitors to always better modulate the protein activity without important side effects. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2014.01.037
  • 作为产物:
    描述:
    参考文献:
    名称:
    亚苄基配体控制 Hoveyda-Grubbs 复分解催化剂引发的显着能力
    摘要:
    螯合亚苄基配体的结构提供了控制 Hoveyda-Grubbs 复分解催化剂引发的独特能力。除了空间和电子效应作用于螯合环打开的步骤之外,与随后的配体交换过程相关的变化也可能起到关键作用。我们的机理模型表明,在亚苄基环的 6 位取代的配体以非最佳螯合构象进入复分解循环,因此钌中心的配位数暂时增加到 6(缔合机制)。实际上,催化剂的合成和引发变得困难,配体交换过程的能垒受配位 OR 基团的结构控制。而且,
    DOI:
    10.1002/ejic.201600435
点击查看最新优质反应信息

文献信息

  • TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES
    申请人:Seayad Abdul Majeed
    公开号:US20110319629A1
    公开(公告)日:2011-12-29
    The present invention relates to titanium catalysts for synthesis reactions produced by bringing a reaction mixture comprising a titanium alkoxide and a ligand in contact with water, wherein the ligand is represented by the general formula (e): wherein R 1 , R 2 , R 3 , and R 4 are independently a hydrogen atom, an alkyl group, or the like, and (A) represents a group with two or more carbon atoms. The titanium catalysts may be isolated in solid form and may be stored. The invention further relates to a process for cyanation of imines, wherein the process comprises reacting an imine with a cyanating agent in the presence of the titanium catalyst.
    本发明涉及一种通过使包含醇盐和配体的反应混合物与接触而制得的用于合成反应的催化剂,其中配体由通式(e)表示:其中R1、R2、R3和R4各自独立地为氢原子、烷基组或其他类似物,且(A)表示具有两个或更多个碳原子的基团。所述催化剂可以以固体形式分离并储存。本发明还涉及一种亚胺化方法,该方法包括在催化剂存在下使亚胺化剂反应。
  • Novel chiral sulfinamide phosphines: valuable precursors to chiral β-aminophosphines
    作者:Peng Chen、Xiao Su、Wei Zhou、Yuanjing Xiao、Junliang Zhang
    DOI:10.1016/j.tet.2015.12.002
    日期:2016.5
    commercially available aldehyde and chiral tert-butanesulfinamide, a series of chiral sulfinamide phosphines (Xiao-Phos) were synthesized via a two-step condensation-nucleophilic addition procedure. In most cases, nucleophilic addition of the N-tert-butanesulfinyl imine with diphenyl methyl phosphonic lithium showed high diastereoselectivity (d.r>20:1) with BF3 as additives. Following removal of the chiral
    从市售的醛和手性叔丁烷亚磺酰胺开始,通过两步缩合亲核加成法合成了一系列手性亚磺酰胺膦(Xiao-Phos)。在大多数情况下,亲核加成的Ñ -叔-butanesulfinyl亚胺碳酸二苯甲基膦表现出较高的非对映选择性(DR> 20:1)与BF 3作为添加剂。除去手性助剂后,使用该方法以高收率获得了重要的一类配体,即手性β-基膦及其衍生物
  • PROCESS FOR PRODUCING OPTICALLY ACTIVE NITROALCOHOLS
    申请人:Yamada Tohru
    公开号:US20050215832A1
    公开(公告)日:2005-09-29
    The present invention relates to a process for producing optically active β-nitroalcohols wherein nitroaldol reactions of aldehydes and nitroalkanes are carried out in the presence of a base and an optically active metal complex catalyst represented by the following formula (c): (where R 4 , R 5 , and R 6 represent a hydrogen atom, an alkyl group, an alkenyl group, an aryl group, an acyl group, an alkoxycarbonyl group, or an aryloxycarbonyl group, and R 5 and R 6 may be linked together to form a ring; X * represents a hydrocarbon group having an asymmetric carbon atom or axial asymmetry; M represents a cobalt ion or a chromium ion; and Y represents an anion capable of forming a salt when the valence of M is larger than that of a ligand).
    本发明涉及一种制备光学活性β-硝基醇的方法,其中在碱和一种由以下式(c)表示的光学活性属配合物催化剂存在下,对醛和硝基烷烃进行硝基醇反应:(式中R4、R5和R6代表氢原子、烷基、烯基、芳基、酰基、烷氧羰基或芳氧羰基,R5和R6可连接在一起形成环;X*代表具有不对称碳原子或轴向不对称的碳氢基团;M代表离子或铬离子;Y代表一种能够在M的价大于配体的情况下形成盐的阴离子)。
  • [EN] TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES<br/>[FR] COMPOSÉS DE TITANE ET PROCÉDÉ DE CYANATION DES IMINES
    申请人:AGENCY SCIENCE TECH & RES
    公开号:WO2010093327A1
    公开(公告)日:2010-08-19
    The present invention relates to titanium catalysts for synthesis reactions produced by bringing a reaction mixture comprising a titanium alkoxide and a ligand in contact with water, wherein the ligand is represented by the general formula (e), wherein R1, R2, R3, and R4 are independently a hydrogen atom, an alkyl group, or the like, and (A) represents a group with two or more carbon atoms. The titanium catalysts may be isolated in solid form and may be stored. The invention further relates to a process for cyanation of imines, wherein the process comprises reacting an imine with a cyanating agent in the presence of the titanium catalyst.
    本发明涉及用于合成反应的催化剂,通过将包含烷氧化物和配体的反应混合物与接触而产生,其中配体由通用公式(e)表示,其中R1、R2、R3和R4分别是氢原子、烷基或类似物,(A)代表具有两个或更多碳原子的基团。这些催化剂可以以固体形式分离并储存。该发明还涉及一种亚胺化过程,其中该过程包括在催化剂存在下将亚胺化剂反应。
  • METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE
    申请人:Yeo Wee Chuan
    公开号:US20100179343A1
    公开(公告)日:2010-07-15
    The present invention relates to a method of producing an optically active cyanohydrin derivative, which comprises reacting an aldehyde or an asymmetrical ketone with a cyanating agent in the presence of a Lewis base and a titanium compound produced from a partial hydrolysate of titanium tetraalkoxide and an optically active ligand represented by formula (II) or a titanium oxoalkoxide compound represented by formula (I) [Ti x O y ](OR 1 ) 4x-2y , and an optically active ligand represented by formula (II), wherein R 1 is an optionally substituted alkyl group or an optionally substituted aryl group; x is an integer of not less than 2; y is an integer of not less than 1; and y/x satisfies 0.1
    本发明涉及一种制备光学活性醇衍生物的方法,包括在Lewis碱和由四烷氧化物的部分解物和式(I)[TixOy](OR1)4x-2y,以及由式(II)表示的光学活性配体组成的氧烷衍生物的存在下,将醛或不对称酮与化试剂反应。其中,R1是可选的取代基的烷基或芳基;x为不小于2的整数;y为不小于1的整数;且y/x满足0.1
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯